Skip to content
Toggle main navigation
Progeria Connect logo
Progeria Connect logo
  • Events
  • Groups
  • Request to join here
    Log in
    Select an available language
    EN

    News

    All
    Events
    Homepage News
    News
    Uncategorized

    Results (34)

    Progeria Research Foundation to Honor Gene-Editing Pioneer David R. Liu, Ph.D., and Peabody Philanthropists Cathy and Dave Gravel at 2026 Night of Wonder Gala

    Progeria Research Foundation to Honor Gene-Editing Pioneer David R. Liu, Ph.D., and Peabody Philanthropists Cathy and Dave Gravel at 2026 Night of Wonder Gala

    Base-editing innovator and longtime local supporters to receive PRF’s S.A.M. Award and Amy Award at biennial signature eventPEABODY, MA, Oct. 7, 2026 /PRNewswire – The Progeria Research Foundation (PRF) will honor gene-editing pioneer David R. Liu, Ph.D., and longtime supporters Cathy and David Gravel of GraVoc at its 2026 Night of Wonder Gala on Saturday, November 14 at the Westin Boston Seaport
    October 7, 2026
    Our 2026 Newsletter is here!

    Our 2026 Newsletter is here!

    2026 PRF NewsletterSeptember 2026 Newsletter pdfThe post Our 2026 Newsletter is here! appeared first on The Progeria Research Foundation.
    September 20, 2026
    The Okie Boys Jet Ski 1,300 Miles for Progeria Research

    The Okie Boys Jet Ski 1,300 Miles for Progeria Research

    The Okie Boys, a group of friends from Oklahoma, just rode jet skis 1,300 miles from Miami to Puerto Rico to raise money for progeria research. The trip started almost as a joke when Derek Hallaway decided to ride his jet skis to his home in Puerto Rico instead of shipping them, but it carried deep personal meaning: his younger brother died of progeria in 2006 at just three and a half years old. T
    July 16, 2026
    PRF’s 12th International Scientific Workshop

    PRF’s 12th International Scientific Workshop

    Maria Eriksson, Vicente Andrés, Mark W. Kieran & Leslie B. GordonPRF Scientific Workshop Summary Published in Nature Aging defines 6 strategic pillars for Progeria research!Two and a half days of groundbreaking science, powerful human connection, and renewed commitment to finding the cure.120PHYSICIANS, SCIENTISTS & ADVOCATES16COUNTRIES REPRESENTED50+SCIENTIFIC PRESENTATIONSIES6STRATEGICPRIORITIES
    July 1, 2026
    NEWS RELEASE: FOR IMMEDIATE RELEASE

    NEWS RELEASE: FOR IMMEDIATE RELEASE

    Sign Upfor OurUpdates! Sign Up Now Together, weWILLfind the cure! Donate Now The post NEWS RELEASE: FOR IMMEDIATE RELEASE appeared first on The Progeria Research Foundation.
    June 30, 2026
    ONEpossible 2026 June 1-July 15. Everywhere

    ONEpossible 2026 June 1-July 15. Everywhere

    GiveJoin the Circle of HopeBecome a Monthly DonorMatching GiftsMake a Planned GiftDonate NowMore Ways to Give ​MEET “THE FAB FOUR!”PART OF OUR EVER-INCREASING POPULATION OF YOUNG ADULTS WITH PROGERIA.Before PRF, the average lifespan for individuals with Progeria was just 13 years. Today, thanks to your support, the development of
    June 4, 2026
    PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!

    PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!

    PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2 – PRF’s investigational gene-editing therapy designed to correct the gene mutation that causes Progeria.This is a defining step toward Progeria gene therapy clinical trials.What is SamPro-2?SamPro-2 is PRF’s gene editing therapy designed to correct the single DNA letter misspelling that causes Progeria.DNA is t
    March 2, 2026
    Get PRF’s 2025 Newletter here!

    Get PRF’s 2025 Newletter here!

    Collaboration = ProgressThe Progerinin trial is a partnership between PRF, trial sponsor PRG Science & Technology (a Korean- based biotech company), Boston Children’s Hospital (the trial site), Brigham and Women’s Hospital (site for some trial tests), and of course the families who are with us every step of the way!Inside, you’ll get:Research Updates: Progerinin Clinical Trial is Well Underway! Ge
    September 25, 2025
    PRF’s Journey to the Cure Featured in New Yorker Magazine

    PRF’s Journey to the Cure Featured in New Yorker Magazine

    The Path to Cure Progeria is Here…After 6 years of intense work, culminating in the final design of the gene therapy drug that could cure Progeria, PRF’s pioneering Gene Editing program is ramping up its next stage of development: manufacturing the drug for human clinical trials.Base editing gene therapy uses CRISPR  technology to target a specific DNA base (or DNA letter) and change it to another
    August 8, 2025
    ONEpossible 2025 June 1-July 15. Everywhere

    ONEpossible 2025 June 1-July 15. Everywhere

    GiveJoin the Circle of HopeBecome a Monthly DonorMatching GiftsMake a Planned GiftDonate NowMore Ways to Give PARALLEL JOURNEYSThanks to the FDA-approved treatment lonafarnib, those with Progeria are living longer and healthier lives, while PRF explores other drugs and genetic therapies that may help even more. They are traveling
    June 1, 2025
    The 2024 Donor Impact Snapshot is here!

    The 2024 Donor Impact Snapshot is here!

    The post The 2024 Donor Impact Snapshot is here! appeared first on The Progeria Research Foundation.
    May 16, 2025
    PRF Co-Founders Drs. Leslie Gordon and Scott Berns speaking as thought leaders at CiMUS, Spain

    PRF Co-Founders Drs. Leslie Gordon and Scott Berns speaking as thought leaders at CiMUS, Spain

    The Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) at the University of Santiago in Spain invited PRF co-founders to share their story at a special Rare Disease Day 2025 event. Organized and moderated by PRF researcher, Dr. Ricardo Villa-Bellosta, Drs. Gordon and Berns will share the latest research advancements impacting the field of Progeria research and the journey of br
    February 27, 2025
    New clinical trial with the drug Progerinin is officially underway

    New clinical trial with the drug Progerinin is officially underway

    PRF is thrilled to announce that the first Progerinin clinical trial patient visits are complete! Earlier this month, we welcomed US-residents Merlin (23) and Kaylee (21) to their week-long trial visits at Boston Children’s Hospital. This groundbreaking trial will explore whether Progerinin, combined with the life-extending drug lonafarnib (Zokinvy), is more effective than lonafarnib alone.  For m
    January 29, 2025
    Long-time friend and PRF supporter Chip Foose supports PRF with truck auction!

    Long-time friend and PRF supporter Chip Foose supports PRF with truck auction!

    Exciting news! Scottsdale, Arizona Jan. 18-26, 2025Renowned automotive designer, artist and long-time PRF supporter Chip Foose has collaborated with RealTruck Inc. on a one-of-a-kind 2021 F-150 truck recently revealed at SEMA (Specialty Equipment Market Association) in Las Vegas. The truck will be auctioned off at Barrett-Jackson in Scottsdale, Arizona in January 2025, with all proceeds benefiting
    January 27, 2025
    Hot off the presses: PRF’s 2024 Newsletter!

    Hot off the presses: PRF’s 2024 Newsletter!

    So much progress, so much to share!! PRF’s 2024 newsletter is rife with exciting updates about our global work – supporting the most promising research toward better treatments and the CURE, and our strategic awareness efforts to find and help all children with Progeria around the world.Inside, you’ll get:the full scoop on the brand-new clinical trial we’re supporting to determine whether the addi
    October 30, 2024
    129th Boston Marathon Official Charity

    129th Boston Marathon Official Charity

    GiveJoin the Circle of HopeBecome a Monthly DonorMatching GiftsMake a Planned GiftDonate NowMore Ways to Give 129th Bank of America Boston Marathon® Official Charity PartnerThe 2025 Progeria Research Foundation Boston Marathon Team The Progeria Research Foundation is proud to be a part of the Boston Athleti
    October 16, 2024
    Mourning the loss of PRF Ambassador, Sammy Basso

    Mourning the loss of PRF Ambassador, Sammy Basso

    The Progeria Research Foundation is honoring the life of our Progeria researcher and PRF spokesperson, Sammy Basso. Sammy sadly passed away at the age of 28 on October 5, 2024.Sammy was the oldest known person living with classic Progeria, which gave him a unique perspective on life and an extraordinary drive to connect with others. He was known and adored throughout the world for his phenomenal o
    October 9, 2024
    BIG NEWS: Announcing the launch of a brand-new clinical drug trial!

    BIG NEWS: Announcing the launch of a brand-new clinical drug trial!

    BIG NEWS: Announcing the launch of a brand-new clinical drug trial!  We’re back at it! PRF is thrilled to announce the start of a new Progeria clinical trial with a new drug called Progerinin. PRF will help fund and coordinate this trial to determine whether a new drug, called Progerinin, plus the life-extending Progeria drug lonafarnib (Zokinvy) is more beneficial than lonaf
    September 30, 2024
    ONEpossible 2024

    ONEpossible 2024

    GiveJoin the Circle of HopeBecome a Monthly DonorMatching GiftsMake a Planned GiftDonate NowMore Ways to Give Good Things Come in 3’s!Niccolo, Alessandro and Sammy are among nearly 100 children and young adults with Progeria across the world who are benefitting from the life-extending, FDA-approved lonafarnib drug. PRF will conti
    June 1, 2024
    PRF now collaborating with Sentynl Therapeutics, new global owner of lonafarnib treatment (Zokinvy®)

    PRF now collaborating with Sentynl Therapeutics, new global owner of lonafarnib treatment (Zokinvy®)

    Effective Friday, May 3rd, 2024, Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd, has acquired global rights to lonafarnib (Zokinvy) from Eiger BioPharmaceuticals (Eiger). Zokinvy® is provided to families worldwide who are using the drug as a treatment for progeria.Based in San Diego, California, Sentynl is focused on providing n
    May 22, 2024
    Contact
    The Progeria Research Foundation
    P.O. Box 3453, Peabody, 01961

    Massachusetts

    USA

    PC@progeriaresearch.org
    (978) 535-2594
    Links
    • Privacy Policy
    • Terms of Use
    • About Sciensus
    • The Progeria Research Foundation
    Community engagement platform by Hivebrite.